FDA Approves New Glucagon Option From Zealand Pharma

This content originally appeared on Beyond Type 1. Republished with permission. By Lala Jackson On March 22, 2021, Zealand Pharma announced the FDA approval of Zegalogue in an autoinjector and prefilled syringe. The approval will add two more easy-to-use glucagon options, joining Eli Lilly’s nasal glucagon Baqsimi and Xeris Pharmaceuticals’ GVOKE HypoPen and prefilled syringe. Slated to […]

What if a Pump Could Deliver Both Insulin and Glucagon?

This content originally appeared on Beyond Type 1. Republished with permission. By Lala Jackson Diabetes technology like insulin pumps and continuous glucose monitors (CGMs) have created less burdensome care routines for people living with diabetes who are able to get them. For some, this tech has also led to lower A1c, more time in range, and fewer […]

Want to Donate Your Unused Diabetes Supplies?

This content originally appeared on diaTribe. Republished with permission. By Eliza Skoler If you’ve got unused diabetes supplies that you no longer need, don’t throw them away! Here are several easy ways that you can donate your supplies to others. If you’ve recently switched to a new diabetes medication or device, you may have leftover diabetes […]

Debate: Should the Artificial Pancreas Include Glucagon? (ADA 2020)

For the millions of people living with type 1 diabetes worldwide, the development of an effective system to automatically regulate blood sugar levels is of paramount significance. Artificial pancreas systems (APS) are being developed with the goals of automatically adjusting the delivery of insulin (and potentially, glucagon) based on glucose readings from a continuous glucose […]

Why Glucagon Is a Must for Sick Days

This content originally appeared on Beyond Type 1. Republished with permission. By Jordan Dakin Common Knowledge Becoming sick when you have type 1 diabetes can easily complicate things. When you have the flu or a serious bacterial infection, your blood sugar levels can quickly become harder to manage, as they typically trend higher because of […]